The FDA has cleared UK-based Ultromics to sell an AI-powered tool for diagnosing coronary artery disease (CAD) on echocardiograms. The product, EchoGo Pro, was tested and validated in the U.S. as well as at the University of Oxford in England.
/PRNewswire/ – A world-first, AI powered, outcomes-driven, decision support tool – EchoGo Pro, has been cleared by the FDA and is now available to clinicians…